Fuyan Shi

Association of <i>PTPRT</i> mutations with immune checkpoint inhibitors response and outcome in melanoma and non‐small cell lung cancer

Wenjing Zhang, Fuyan Shi, Yujia Kong et al. · Cancer Medicine · 2021 · 70 citations · Full text

Life Sciences, Immunology, Oncology +17

Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP)

Linong Ji, Weihong Song, Hui Fang et al. · Science Bulletin · 2021 · 63 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The association between ambient temperature and mortality of the coronavirus disease 2019 (COVID-19) in Wuhan, China: a time-series analysis

Gaopei Zhu, Yuhang Zhu, Zhongli Wang et al. · BMC Public Health · 2021 · 39 citations · Full text

Veterinary Medicine, Infectious Diseases, Epidemiologic Methods +12

Household income, income inequality, and health-related quality of life measured by the EQ-5D in Shaanxi, China: a cross-sectional study

Zhijun Tan, Fuyan Shi, Haiyue Zhang et al. · International Journal for Equity in Health · 2018 · 36 citations · Full text

Public Health, Health Sciences, Population Health Sciences +17

Sex Disparities of Genomic Determinants in Response to Immune Checkpoint Inhibitors in Melanoma

Fuyan Shi, Wenjing Zhang, Yichen Yang et al. · Frontiers in Immunology · 2021 · 30 citations · Full text

Life Sciences, Genetics, Oncology +17